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Background
The development and application of standardised sets of
outcomes to be measured and reported in clinical trials
have the potential to increase the efficiency and value of
research. One of the most notable of the current out-
come sets was developed nearly 20 years ago: the World
Health Organisation (WHO) and International League
of Associations for Rheumatology (ILAR) core set of
outcomes for rheumatoid arthritis clinical trials, origi-
nating from the OMERACT (Outcome Measures in
Rheumatology) Initiative.
Methods
A review of 350 randomised trials for the treatment of
rheumatoid arthritis identified through The Cochrane
Library. Reports of these trials were evaluated to deter-
mine whether or not there was a trend in the proportion
of studies reporting on the full set of core outcomes over
time. Researchers who conducted trials after the publica-
tion of the core set were contacted to assess their aware-
ness of it and to collect reasons for non-inclusion of the
full core set of outcomes in the study.
Results
This review suggests that 60-70% of trialists conducting
trials in rheumatoid arthritis are now measuring the
rheumatoid arthritis core outcome set. 90% of trialists
that responded said that they would consider using the
core outcome set in the design of a new study.
Conclusions
This review suggests that a higher percentage of trialists
conducting trials in rheumatoid arthritis are now mea-
suring the rheumatoid arthritis core outcome set. Core
outcome sets have the potential to improve the evidence
base for health care.
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